ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,271, issued on Nov. 18, was assigned to Gilead Sciences Inc. (Foster City, Calif.).
"GLP-1R modulating compounds" was invented by Gediminas J. Brizgys (San Carlos, Calif.), James S. Cassidy (San Francisco), Chienhung Chou (Dublin, Calif.), Jeromy J. Cottell (Redwood City, Calif.), Chao-I Hung (San Mateo, Calif.), Kavoos Kolahdouzan (San Francisco), James G. Taylor (Burlingame, Calif.), Nathan E. Wright (San Diego) and Zheng-Yu Yang (Palo Alto, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides GLP-1R agonists, and compositions, methods, and kits thereof. Such compounds are generally useful for treating a GLP-1R med...